ES7R
TEAS SECTION 7 REQUEST RECEIVED
08/23/2024
Back to search
Official data from USPTO
JUXTAPID
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
30
Latest update
08/23/2024
Classification
Registered
Trademark type
Combined
Nice classes
44
Filing date
12/28/2021
Registration date
08/29/2023
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
08/29/2023
Last transaction
08/23/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
11/01/2020
First use in commerce
11/01/2020
Drawing code
3
Owner type
03
Owner location
Boston, MA
Examiner
LEE, SANG MIN
Law office
M20
Current location
TMO LAW OFFICE 111
Mark description
The mark consists of the red stylized wording "JUXTAPID" with blue eccentric circles surrounding the dot in the letter "I"
Holders and representatives
Holders
Amryt Pharmaceuticals Inc.
Representatives
Richard Todd Armstrong CLARK+ELBING LLP
Technical classification
Nice Classes
Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 44
Medical information
Publications
History of USPTO decisions and trademark events.
30 publications found
NURC
NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED
05/28/2024
COC.
CORRECTION UNDER SECTION 7 - PROCESSED
04/25/2024
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
04/23/2024
ES7R
TEAS SECTION 7 REQUEST RECEIVED
09/22/2023
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
08/29/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
08/29/2023
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
07/22/2023
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
07/21/2023
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
07/12/2023
SUPC
STATEMENT OF USE PROCESSING COMPLETE
07/11/2023
EX1G
SOU EXTENSION 1 GRANTED
07/11/2023
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
07/11/2023
EXT1
SOU EXTENSION 1 FILED
07/03/2023
IUAF
USE AMENDMENT FILED
07/03/2023
EEXT
SOU TEAS EXTENSION RECEIVED
07/03/2023
EISU
TEAS STATEMENT OF USE RECEIVED
07/03/2023
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
01/03/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11/08/2022
PUBO
PUBLISHED FOR OPPOSITION
11/08/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
10/19/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/05/2022
XAEC
EXAMINER'S AMENDMENT ENTERED
10/05/2022
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
10/05/2022
GNEA
EXAMINERS AMENDMENT E-MAILED
10/05/2022
CNEA
EXAMINERS AMENDMENT -WRITTEN
10/05/2022
DOCK
ASSIGNED TO EXAMINER
09/29/2022
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
01/05/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
01/04/2022
NWAP
NEW APPLICATION ENTERED
12/31/2021
Continuous trademark protection
Get notified about every new filing that threatens JUXTAPID or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.